Medtronic: Big plans in 2021Medtronic (NYSE:MDT) meanwhile continues to work on its new Hugo system that is meant to rival Intuitive Surgical’s da Vinci robots. CEO Geoff Martha said in August that the world’s largest medical device company had been able to manage through previously disclosed disruptions related to COVID-19 — as well as resolving software issues. The plan is to file for CE Mark and U.S. IDE approval in early 2021.
“We’re going to be a meaningful player in this market. Go big or go home,” Martha said.
In the orthopedics space, Medtronic is looking to add enhancements to its Mazor X spinal robotic system.